Daily Archives: Thursday September 3rd, 2020

Helse Vest’s reasearch and innovation awards

Helse Vest RHF annually awards two prizes: a research prize and an innovation prize. The prizes will be awarded at the annual Research Conference in the autumn, and we encourage the various research environments in K2 to apply.

Helse Vest’s research award

The award is given to a researcher, research environment or young researcher (under the age of 40) who, through his or her research, has contributed to strengthening a research field or a research-based health service offering. The research must be of a nature and standard of significance for the level of research and / or the service offer in the region. Candidates (researcher, research environment or young researcher) who have contributed to the development of either a) research area, b) research collaboration / environment or c) who through their research have improved clinical practice in Helse Vest can be proposed.

The following form (Norwegian only): Forslagsskjema 2020- forskingspris og innovasjonspris should be filled in by the proposer.

Helse Vest’s annual research prize consists of NOK 200,000 and a work of art. The prize amount will be used for further research.

Helse Vest’s innovation award

The innovation prize is awarded to one or more persons who, through their work, have contributed to the development of a new or improved product, service, production process or organizational form that constitutes a concept that can be reused in the health sector. The award can be given both on the basis of research-driven and demand-driven innovation. The development must be made visible through the idea / innovation project being either reported and / or further developed together with the regional office of Innovation Norway, InnoMed, the Research Council of Norway or one of the region’s two Technology Transfer Offices (TTO). Similarly, internal projects that have not been made visible through the mentioned actors will also be considered. In such cases, it will be important that the product, process or services have been used, and it can be demonstrated to what benefit the innovation has had for the hospital.

A separate form (Norwegian only): Forslagsskjema 2020- forskingspris og innovasjonspris has been prepared to be filled in by the proposer.

The innovation award consists of NOK 100,000 and a work of art. The prize amount will be used for further innovation work.

Continue reading

Norwegian: Unngå identitetstyveri!

Visste du at flerfaktor-autentisering er den mest effektive måten å beskytte seg mot identitetstyveri?
Dette vil hindre at noen kan logge inn på kontoen din selv om passordet ditt skulle komme på avveie.

IT-Avdelingen ved UiB tilbyr flerfaktor-autentisering til alle ansatte og studenter. Den gjelder i første omgang Office 365 og VPN; flere tjenester vil bli lagt til fortløpende.

Aktiver flerfaktor-autentisering på kontoen din NÅ ved å gå inn på it.uib.no/MFA.

New positions: PhD-position and Postdoctoral Research Fellow

15 PhD-positions and 3 Postdoctoral Research Fellows are available from the Faculty of Medicine starting 1 February 2021 with application deadline 20 September 2020.

PhD-position: https://www.jobbnorge.no/en/available-jobs/job/191844/phd-position-15-positions

Postdoctoral: https://www.jobbnorge.no/en/available-jobs/job/191826/postdoctoral-research-fellow-3-positions

Continue reading

Master projects for the biomedical students 2020-2021

The program committee on the Institute of Biomedicine want the scientific staff to offer master projects for the biomedical students. The project will take place from the fall 2021 to the spring of 2022. Please use MAL Projectdescription.

We will arrange an event for students and supervisors during this semester. The students will get a chance to meet potential supervisors, and the scientists get the opportunity to present their research. We will send out details about this later. We hope you want to attend this! More information: VEILEDER INFO_

Please send your master projects by 18th of September to siri.aaserud@uib.no or to studie@biomed.uib.no.

Norwegian: Gjesteforelesning: SLE – disease mechanisms, clinical features and prognosis

Gjesteforelesning på K2 og Avdeling for Reumatologi, 10. september 2020, kl 15:00

SLE – disease mechanisms, clinical features and prognosis

Foredragsholder: Professor og overlege Anders Bengtsson, Lunds Universitet og Skånes Universitetssjukhus

Professor Bengtsson er en av Sverige ledende revmatologer med systemisk lupus erytematosus (SLE) som spesialfelt. På torsdag holder han en state-of-the-art forelesning om SLE.

For å få tilsendt lenke / møteinvitasjon til foredraget, vennligst registrer deg på følgende skjemaker:


This week`s employee – Simona Chera

What are you working on?

I work as an associate professor at the Center for Diabetes Research, K2. My research is directed at how cell death features govern the type of regenerative strategy employed by a biological system. By coupling classical and newly generated murine models of cell loss with genetic cell tracing, timed conditional gene expression and omics assays (transcriptomics, proteomics, scRNAseq), I study the dynamic molecular fingerprint of pancreatic islet cells decay and regeneration, with focus on self-renewal and global regulators of cell identity maintenance processes. Besides the in vivo approach, I use patient-specific induced pluripotent stem cells (hiPSC) as disease models coupled with large-scale imaging and omics for studying islet cell fate acquisition and maintenance. We are also developing a 3D culture system to investigate the influence of mechanical forces and adhesion on signaling pathways controlling the pancreatic progenitors’ differentiation potential. Our goal is to enlarge the knowledge base about pancreatic islet biology in order to create a better treatment for diabetes, or preventive measures in the future. My personal goal is to induce at least a certain level of endogenous regeneration of the pancreatic islets as seen in highly regenerative animals (like hydra, salamander or fish). My career started by working on such a successful regenerative system, and during my PhD work at University of Geneva, we described that apoptotic cells resulted upon injury were the source of regenerative signals. During my postdoctoral work (University of Geneva), I started working on pancreatic islet regeneration and showed that the mammalian pancreas also exhibits, at a very low level, an endogenous regenerative capacity. A better understanding of how islet cells are formed during development will also improve future regenerative strategies.

What do you enjoy working with at K2?

I started working here five years ago, which gave me the opportunity to get to know the tools and needs of clinical research. I am part of a very heterogeneous multidisciplinary group of researchers, integrating genomics, molecular and cellular biology, bioinformatics and clinical research. We all study diabetes but different aspects of the disease from the molecular mechanisms to clinical aspects. I like the challenge of learning how to effectively communicate with scientists from different disciplines, and to see the diabetes research from so many other points of view. Being so close to the clinics at K2 also changed my perspective over my own research, especially regarding motivation and impact.

New publications

Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 7 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Oda Barth Vedøy.

Continue reading